173 related articles for article (PubMed ID: 35078942)
1. Simplified and more sensitive criteria for identifying individuals with pathogenic
Lerner BA; Xicola RM; Rodriguez NJ; Karam R; Llor X
J Med Genet; 2023 Jan; 60(1):36-40. PubMed ID: 35078942
[TBL] [Abstract][Full Text] [Related]
2. Clinical Implication of CDH1 Mutations in Genetic Testing for Diffuse Gastric Cancer Patients.
Corso G; Trovato CM; Petitto S; Girardi A; De Scalzi AM; Bianchi B; Magnoni F; Cioffi A; Galimberti V; Veronesi P; Mazzarol G; Maisonneuve P
Oncology; 2024; 102(4):374-379. PubMed ID: 37725907
[TBL] [Abstract][Full Text] [Related]
3. Genotype-first approach to identify associations between CDH1 germline variants and cancer phenotypes: a multicentre study by the European Reference Network on Genetic Tumour Risk Syndromes.
Garcia-Pelaez J; Barbosa-Matos R; Lobo S; Dias A; Garrido L; Castedo S; Sousa S; Pinheiro H; Sousa L; Monteiro R; Maqueda JJ; Fernandes S; Carneiro F; Pinto N; Lemos C; Pinto C; Teixeira MR; Aretz S; Bajalica-Lagercrantz S; Balmaña J; Blatnik A; Benusiglio PR; Blanluet M; Bours V; Brems H; Brunet J; Calistri D; Capellá G; Carrera S; Colas C; Dahan K; de Putter R; Desseignés C; Domínguez-Garrido E; Egas C; Evans DG; Feret D; Fewings E; Fitzgerald RC; Coulet F; Garcia-Barcina M; Genuardi M; Golmard L; Hackmann K; Hanson H; Holinski-Feder E; Hüneburg R; Krajc M; Lagerstedt-Robinson K; Lázaro C; Ligtenberg MJL; Martínez-Bouzas C; Merino S; Michils G; Novaković S; Patiño-García A; Ranzani GN; Schröck E; Silva I; Silveira C; Soto JL; Spier I; Steinke-Lange V; Tedaldi G; Tejada MI; Woodward ER; Tischkowitz M; Hoogerbrugge N; Oliveira C
Lancet Oncol; 2023 Jan; 24(1):91-106. PubMed ID: 36436516
[TBL] [Abstract][Full Text] [Related]
4. Clinical features and cancer risk in families with pathogenic
Xicola RM; Li S; Rodriguez N; Reinecke P; Karam R; Speare V; Black MH; LaDuca H; Llor X
J Med Genet; 2019 Dec; 56(12):838-843. PubMed ID: 31296550
[TBL] [Abstract][Full Text] [Related]
5. Accuracy of Hereditary Diffuse Gastric Cancer Testing Criteria and Outcomes in Patients With a Germline Mutation in CDH1.
van der Post RS; Vogelaar IP; Manders P; van der Kolk LE; Cats A; van Hest LP; Sijmons R; Aalfs CM; Ausems MG; Gómez García EB; Wagner A; Hes FJ; Arts N; Mensenkamp AR; van Krieken JH; Hoogerbrugge N; Ligtenberg MJ
Gastroenterology; 2015 Oct; 149(4):897-906.e19. PubMed ID: 26072394
[TBL] [Abstract][Full Text] [Related]
6. Cancer predisposition and germline CTNNA1 variants.
Lobo S; Benusiglio PR; Coulet F; Boussemart L; Golmard L; Spier I; Hüneburg R; Aretz S; Colas C; Oliveira C
Eur J Med Genet; 2021 Oct; 64(10):104316. PubMed ID: 34425242
[TBL] [Abstract][Full Text] [Related]
7. Identification of c.1531C>T Pathogenic Variant in the
Norero E; Alarcon MA; Hakkaart C; de Mayo T; Mellado C; Garrido M; Aguayo G; Lagos M; Torres J; Calvo A; Guilford P; Corvalan AH
Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31600923
[TBL] [Abstract][Full Text] [Related]
8. Cleft lip/palate and hereditary diffuse gastric cancer: report of a family harboring a CDH1 c.687 + 1G > A germline mutation and review of the literature.
Obermair F; Rammer M; Burghofer J; Malli T; Schossig A; Wimmer K; Kranewitter W; Mayrbaeurl B; Duba HC; Webersinke G
Fam Cancer; 2019 Apr; 18(2):253-260. PubMed ID: 30306390
[TBL] [Abstract][Full Text] [Related]
9. Screening E-cadherin in gastric cancer families reveals germline mutations only in hereditary diffuse gastric cancer kindred.
Oliveira C; Bordin MC; Grehan N; Huntsman D; Suriano G; Machado JC; Kiviluoto T; Aaltonen L; Jackson CE; Seruca R; Caldas C
Hum Mutat; 2002 May; 19(5):510-7. PubMed ID: 11968083
[TBL] [Abstract][Full Text] [Related]
10. Germline CDH1 variants in hereditary diffuse gastric cancer syndrome with focus on younger women.
Corso G; Comelli G; Veronesi P; Bianchi B; Petitto S; Polizzi A; Girardi A; Cioffi A; La Vecchia C; Bagnardi V; Magnoni F
J Cancer Res Clin Oncol; 2023 Nov; 149(17):16147-16155. PubMed ID: 37639007
[TBL] [Abstract][Full Text] [Related]
11. Associations of CDH1 germline variant location and cancer phenotype in families with hereditary diffuse gastric cancer (HDGC).
Lo W; Zhu B; Sabesan A; Wu HH; Powers A; Sorber RA; Ravichandran S; Chen I; McDuffie LA; Quadri HS; Beane JD; Calzone K; Miettinen MM; Hewitt SM; Koh C; Heller T; Wacholder S; Rudloff U
J Med Genet; 2019 Jun; 56(6):370-379. PubMed ID: 30745422
[TBL] [Abstract][Full Text] [Related]
12. Outcomes of Endoscopic Surveillance in Individuals With Genetic Predisposition to Hereditary Diffuse Gastric Cancer.
Jacobs MF; Dust H; Koeppe E; Wong S; Mulholland M; Choi EY; Appelman H; Stoffel EM
Gastroenterology; 2019 Jul; 157(1):87-96. PubMed ID: 30935944
[TBL] [Abstract][Full Text] [Related]
13.
Ben Aissa-Haj J; Kabbage M; Othmen H; Saulnier P; Kettiti HT; Jaballah-Gabteni A; Ferah A; Medhioub M; Khsiba A; Mahmoudi M; Maaloul A; Ben Nasr S; Chelbi E; Abdelhak S; Boubaker MS; Azzouz MM; Rouleau E
Genes (Basel); 2022 Feb; 13(3):. PubMed ID: 35327954
[TBL] [Abstract][Full Text] [Related]
14. Germline likely pathogenic variants in ataxia-telangiectasia-mutated gene in an Iranian family with hereditary diffuse gastric cancer without
Kheirollahi M; Saneipour M; Moridnia A
J Cancer Res Ther; 2021; 17(6):1434-1437. PubMed ID: 34916374
[TBL] [Abstract][Full Text] [Related]
15. Hereditary diffuse gastric cancer and E-cadherin: description of the first germline mutation in an Italian family.
Roviello F; Corso G; Pedrazzani C; Marrelli D; De Falco G; Berardi A; Garosi L; Suriano G; Vindigni C; De Stefano A; Leoncini L; Seruca R; Pinto E
Eur J Surg Oncol; 2007 May; 33(4):448-51. PubMed ID: 17126523
[TBL] [Abstract][Full Text] [Related]
16.
Corso G; Magnoni F; Massari G; Trovato CM; De Scalzi AM; Vicini E; Bonanni B; Veronesi P; Galimberti V; Bagnardi V
J Med Genet; 2022 Apr; 59(4):313-317. PubMed ID: 34952833
[TBL] [Abstract][Full Text] [Related]
17. CDH1 germline mutations in a Chinese cohort with hereditary diffuse gastric cancer.
Pan Z; Fu Z; Luo C; Bao Y; Wang M; Cao W; Xu X
J Cancer Res Clin Oncol; 2022 Aug; 148(8):2145-2151. PubMed ID: 34537906
[TBL] [Abstract][Full Text] [Related]
18. CDH1 gene mutations do not contribute in hereditary diffuse gastric cancer in Poland.
Jakubowska A; Lawniczak M; Wojnarska B; Cybulski C; Huzarski T; Byrski T; Tołoczko-Grabarek A; Jaworska K; Durda K; Starzyńska T; Lubiński J
Fam Cancer; 2010 Dec; 9(4):605-8. PubMed ID: 20842455
[TBL] [Abstract][Full Text] [Related]
19. Combined loss of CDH1 and downstream regulatory sequences drive early-onset diffuse gastric cancer and increase penetrance of hereditary diffuse gastric cancer.
São José C; Garcia-Pelaez J; Ferreira M; Arrieta O; André A; Martins N; Solís S; Martínez-Benítez B; Ordóñez-Sánchez ML; Rodríguez-Torres M; Sommer AK; Te Paske IBAW; Caldas C; Tischkowitz M; Tusié MT; ; Hoogerbrugge N; Demidov G; de Voer RM; Laurie S; Oliveira C
Gastric Cancer; 2023 Sep; 26(5):653-666. PubMed ID: 37249750
[TBL] [Abstract][Full Text] [Related]
20. A novel truncating mutation in the E-cadherin gene in the first Iranian family with hereditary diffuse gastric cancer.
Ghaffari SR; Rafati M; Sabokbar T; Dastan J
Eur J Surg Oncol; 2010 Jun; 36(6):559-62. PubMed ID: 20471195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]